This article is more than 5 years old. Information may no longer be current.

Amedica announces second-generation interbody fusion device

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Amedica Corporation recently announced the release of its second-generation silicon nitride transforaminal lumbar interbody fusion device.

The Valeo II TL interbody fusion device is designed to maximize central cavity space for autograft packing and includes optimized instrumentation, according to a company press release.

Made of a micro-composite silicon nitride biomaterial, the new device is indicated for intervertebral body fusion of the spine in skeletally mature patients and is designed for use with autograft to facilitate fusion.

“This second-generation TL device, in tandem with our anterior, posterior and oblique lumbar second-generation silicon nitride interbody devices, greatly strengthens our ability to capture additional share within the $1.4 billion spinal interbody fusion device market,” Eric Olson, CEO of Amedica, said in the release.

Reference: www.amedica.com